{"id":"https://openalex.org/W4404171237","doi":"https://doi.org/10.4049/jimmunol.212.supp.0983.5731","title":"A novel lentiviral vector-based approach to generate CAR T cells targeting Aspergillus fumigatus","display_name":"A novel lentiviral vector-based approach to generate CAR T cells targeting Aspergillus fumigatus","publication_year":2024,"publication_date":"2024-05-01","ids":{"openalex":"https://openalex.org/W4404171237","doi":"https://doi.org/10.4049/jimmunol.212.supp.0983.5731"},"language":"en","primary_location":{"id":"doi:10.4049/jimmunol.212.supp.0983.5731","doi":"https://doi.org/10.4049/jimmunol.212.supp.0983.5731","is_oa":false,"landing_page_url":"https://doi.org/10.4049/jimmunol.212.supp.0983.5731","pdf_url":null,"source":{"id":"https://openalex.org/S38008053","display_name":"The Journal of Immunology","issn_l":"0022-1767","issn":["0022-1767","1550-6606"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-2","ki-jl-2","medline","norway-2"],"host_organization":"https://openalex.org/P4320800377","host_organization_name":"American Association of Immunologists","host_organization_lineage":["https://openalex.org/P4320800377"],"host_organization_lineage_names":["American Association of Immunologists"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Immunology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081355136","display_name":"Pappanaicken R. Kumaresan","orcid":"https://orcid.org/0000-0001-7788-3241","observed_orcids":["https://orcid.org/0000-0001-7788-3241"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pappanaicken Kumaresan","raw_affiliation_strings":["Univ. of Texas MD Anderson Cancer Ctr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ. of Texas MD Anderson Cancer Ctr","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040800962","display_name":"Sebastian Wurster","orcid":"https://orcid.org/0000-0002-7784-7256","observed_orcids":["https://orcid.org/0000-0002-7784-7256"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sebastian Wurster","raw_affiliation_strings":["Univ. of Texas MD Anderson Cancer Ctr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ. of Texas MD Anderson Cancer Ctr","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Thiago da Silva","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I17974374","display_name":"Universidade de S\u00e3o Paulo","ror":"https://ror.org/036rp1748","country_code":"BR","type":"education","lineage":["https://openalex.org/I17974374"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Thiago da Silva","raw_affiliation_strings":["Univ. of S\u00e3o Paulo Fac. of Med"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ. of S\u00e3o Paulo Fac. of Med","institution_ids":["https://openalex.org/I17974374"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114566044","display_name":"Karishma Bavasi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karishma Bavasi","raw_affiliation_strings":["Univ. of Texas MD Anderson Cancer Ctr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ. of Texas MD Anderson Cancer Ctr","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112846027","display_name":"Nathaniel D. Albert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nathaniel Albert","raw_affiliation_strings":["Univ. of Texas MD Anderson Cancer Ctr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ. of Texas MD Anderson Cancer Ctr","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010743791","display_name":"Paul J. Hauser","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul Hauser","raw_affiliation_strings":["Univ. of Texas MD Anderson Cancer Ctr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ. of Texas MD Anderson Cancer Ctr","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064752432","display_name":"Sattva Swarup Neelapu","orcid":"https://orcid.org/0000-0003-1045-4914","observed_orcids":["https://orcid.org/0000-0003-1045-4914"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sattva Neelapu","raw_affiliation_strings":["Univ. of Texas MD Anderson Cancer Ctr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ. of Texas MD Anderson Cancer Ctr","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5041039527","display_name":"Dimitrios P. Kontoyiannis","orcid":"https://orcid.org/0000-0002-8051-2940","observed_orcids":["https://orcid.org/0000-0002-8051-2940"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dimitrios Kontoyiannis","raw_affiliation_strings":["Univ. of Texas MD Anderson Cancer Ctr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ. of Texas MD Anderson Cancer Ctr","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3710,"currency":"USD","value_usd":3710},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"212","issue":"1_Supplement","first_page":"0983_5731","last_page":"0983_5731"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9531000256538391,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9531000256538391,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.014600000344216824,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10878","display_name":"CRISPR and Genetic Engineering","score":0.003700000001117587,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aspergillus-fumigatus","display_name":"Aspergillus fumigatus","score":0.9020000100135803},{"id":"https://openalex.org/keywords/invasive-aspergillosis","display_name":"invasive aspergillosis","score":0.8920000195503235},{"id":"https://openalex.org/keywords/chimeric-antigen-receptor-t-cells","display_name":"chimeric antigen receptor T cells","score":0.8629999756813049},{"id":"https://openalex.org/keywords/lentiviral-vectors","display_name":"lentiviral vectors","score":0.9179999828338623},{"id":"https://openalex.org/keywords/chimeric-antigen-receptor","display_name":"chimeric antigen receptor","score":0.8299999833106995},{"id":"https://openalex.org/keywords/single-chain-variable-fragment","display_name":"scFv","score":0.6510000228881836},{"id":"https://openalex.org/keywords/mycelial-growth-inhibition","display_name":"mycelial growth inhibition","score":0.6830000281333923},{"id":"https://openalex.org/keywords/nsg-mice","display_name":"NSG mice","score":0.597000002861023},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.546999990940094},{"id":"https://openalex.org/keywords/antifungal-immunity","display_name":"antifungal immunity","score":0.5799999833106995}],"concepts":[{"id":"https://openalex.org/C2779787849","wikidata":"https://www.wikidata.org/wiki/Q134359","display_name":"Aspergillus fumigatus","level":2,"score":0.8009457588195801},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.565902590751648},{"id":"https://openalex.org/C32470452","wikidata":"https://www.wikidata.org/wiki/Q2298489","display_name":"Viral vector","level":4,"score":0.5358112454414368},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.508030891418457},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.47806480526924133},{"id":"https://openalex.org/C92087593","wikidata":"https://www.wikidata.org/wiki/Q427389","display_name":"Vector (molecular biology)","level":4,"score":0.47564220428466797},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.38685688376426697},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.15115207433700562},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.14448437094688416},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.07778686285018921}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.4049/jimmunol.212.supp.0983.5731","doi":"https://doi.org/10.4049/jimmunol.212.supp.0983.5731","is_oa":false,"landing_page_url":"https://doi.org/10.4049/jimmunol.212.supp.0983.5731","pdf_url":null,"source":{"id":"https://openalex.org/S38008053","display_name":"The Journal of Immunology","issn_l":"0022-1767","issn":["0022-1767","1550-6606"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-2","ki-jl-2","medline","norway-2"],"host_organization":"https://openalex.org/P4320800377","host_organization_name":"American Association of Immunologists","host_organization_lineage":["https://openalex.org/P4320800377"],"host_organization_lineage_names":["American Association of Immunologists"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Immunology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.8100000023841858,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2036410003","https://openalex.org/W3032277478","https://openalex.org/W2379772182","https://openalex.org/W2018609975","https://openalex.org/W2394205039","https://openalex.org/W2035639831","https://openalex.org/W2094639259","https://openalex.org/W178659070","https://openalex.org/W2363461183","https://openalex.org/W2331378378"],"abstract_inverted_index":{"Abstract":[0],"Invasive":[1],"aspergillosis":[2,132],"(IA)":[3],"is":[4],"a":[5,43,61,178],"common":[6],"and":[7,16,60,75,79,86,106,146,160,197],"deadly":[8],"mold":[9],"infection":[10,150],"in":[11,195,200],"immunocompromised":[12],"patients.":[13],"As":[14],"morbidity":[15,154],"mortality":[17],"of":[18,57,72,83,101,118,123,137],"IA":[19],"are":[20,37],"primarily":[21],"driven":[22],"by":[23],"poor":[24],"immune":[25],"defense,":[26],"adjunct":[27],"immunotherapies,":[28],"such":[29],"as":[30],"chimeric":[31],"antigen":[32],"receptor":[33],"(CAR)":[34],"T":[35,51,93,141,172,185],"cells,":[36],"direly":[38],"needed.":[39],"Here,":[40],"we":[41,176],"propose":[42],"novel":[44,179],"approach":[45],"to":[46,167,182],"generate":[47],"Aspergillus":[48],"fumigatus":[49],"(AF)-CAR":[50],"cells":[52,66,94,100,142,186],"using":[53],"the":[54],"scFv":[55],"domain":[56],"AF-269-5":[58],"mAb":[59],"lentiviral":[62,180],"vector":[63],"system.":[64],"These":[65],"successfully":[67],"targeted":[68],"mature":[69],"hyphal":[70],"filaments":[71],"representative":[73],"clinical":[74],"reference":[76],"AF":[77,149],"isolates":[78],"elicited":[80],"potent":[81],"release":[82],"cytotoxic":[84],"effectors":[85],"type":[87],"1":[88],"T-cell":[89],"cytokines.":[90],"Furthermore,":[91],"AF-CAR":[92,140,184],"generated":[95],"from":[96],"peripheral":[97],"blood":[98],"mononuclear":[99],"four":[102],"healthy":[103],"human":[104],"donors":[105],"expanded":[107],"with":[108,129,187],"cytokine":[109],"stimulation":[110],"(IL-2,":[111],"IL-7+IL-15)":[112],"regimens":[113],"significantly":[114,152,161],"suppressed":[115],"mycelial":[116],"growth":[117],"AF-293":[119],"after":[120,148],"18":[121],"h":[122],"co-culture.":[124],"Moreover,":[125],"cyclophosphamide-immunosuppressed":[126],"NSG":[127],"mice":[128,168],"invasive":[130],"pulmonary":[131],"that":[133],"received":[134],"two":[135],"doses":[136],"5":[138],"million":[139],"on":[143,155],"days":[144],"0":[145],"2":[147],"showed":[151],"reduced":[153],"day":[156],"4":[157],"post-infection":[158],"(p<0.001)":[159],"improved":[162],"7-day":[163],"survival":[164],"(p=0.049)":[165],"compared":[166],"receiving":[169],"non-targeting":[170],"control":[171],"cells.":[173],"In":[174],"conclusion,":[175],"developed":[177],"strategy":[181],"obtain":[183],"high":[188],"targeting":[189],"efficacy,":[190],"yielding":[191],"significant":[192],"anti-AF":[193],"activity":[194],"vitro":[196],"short-term":[198],"protection":[199],"vivo.":[201]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2025-10-10T00:00:00"}
